• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可切除食管癌放疗后的生存情况及食管通畅情况。106例回顾性研究。

Survival and esophageal passage after radiotherapy of inoperable esophageal carcinoma. A retrospective study of 106 cases.

作者信息

Kellokumpu-Lehtinen P, Huovinen R, Nikkanen V

机构信息

Department of Radiotherapy, University Central Hospital, Turku, Finland.

出版信息

Acta Oncol. 1990;29(2):175-8. doi: 10.3109/02841869009126541.

DOI:10.3109/02841869009126541
PMID:2334570
Abstract

Survival and esophageal passage were studied retrospectively in 106 patients with inoperable esophageal carcinoma treated with radiotherapy during the years 1972 to 1983. The survival rates were 30%, 13% and 7% at one, two and three years respectively. The survival rate for the female patients was significantly better than for the males throughout these three years; 9% of the female patients lived for three years compared to only 3% of the male patients. Forty-two percent of the patients received 'radical' irradiation (greater than 50 Gy). The 3-year survival rate was 16% after a tumor dose of 50 Gy or more, and zero with a dose less than 50 Gy, but this difference might be explained by selection factors, such as patients in poor general condition not receiving 'radical' irradiation. Esophageal passage after radiotherapy could be evaluated in 62 patients, and 22 (35%) of them required feeding gastrostomy due to esophageal discontinuity, most often within one year after completion of radiotherapy. It is concluded that radiotherapy has only a slight effect on the prognosis of inoperable esophageal carcinoma.

摘要

对1972年至1983年间接受放疗的106例无法手术的食管癌患者的生存情况和食管通畅情况进行了回顾性研究。1年、2年和3年的生存率分别为30%、13%和7%。在这三年中,女性患者的生存率明显高于男性;9%的女性患者存活了三年,而男性患者仅为3%。42%的患者接受了“根治性”放疗(大于50 Gy)。肿瘤剂量达到50 Gy或更高时,3年生存率为16%,剂量低于50 Gy时为零,但这种差异可能是由选择因素造成的,比如一般状况较差的患者未接受“根治性”放疗。62例患者放疗后的食管通畅情况可进行评估,其中22例(35%)因食管连续性中断需要行胃造瘘术进食,多数发生在放疗结束后一年内。结论是,放疗对无法手术的食管癌预后影响甚微。

相似文献

1
Survival and esophageal passage after radiotherapy of inoperable esophageal carcinoma. A retrospective study of 106 cases.不可切除食管癌放疗后的生存情况及食管通畅情况。106例回顾性研究。
Acta Oncol. 1990;29(2):175-8. doi: 10.3109/02841869009126541.
2
External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.外照射放疗联合高剂量率近距离放疗用于不可切除的表浅食管癌治疗
Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1456-61. doi: 10.1016/j.ijrobp.2006.02.049.
3
The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer.放射治疗对食管癌患者吞咽困难及生存的影响。
Radiother Oncol. 1988 May;12(1):15-23. doi: 10.1016/0167-8140(88)90188-0.
4
[Radiotherapy of inoperable esophageal cancer. Retrospective analysis apropos of 108 cases].[不可切除食管癌的放射治疗。关于108例病例的回顾性分析]
Bull Cancer Radiother. 1990;77(1):69-76.
5
Outcomes from chemoradiotherapy for patients with esophageal cancer.食管癌患者的放化疗结果。
Dis Esophagus. 2011 Apr;24(3):172-6. doi: 10.1111/j.1442-2050.2010.01121.x. Epub 2010 Nov 12.
6
Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.食管癌放疗:总治疗时间和分割方式的影响
Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1099-105. doi: 10.1016/0360-3016(94)90315-8.
7
[Radiotherapy of esophageal carcinoma: an assessment of patients treated at Tübingen from 1977 to 1982].[食管癌的放射治疗:对1977年至1982年在图宾根接受治疗的患者的评估]
Strahlenther Onkol. 1989 Jan;165(1):1-10.
8
Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.食管癌的综合治疗:一项大型澳大利亚多中心研究的初步结果。
Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):997-1006. doi: 10.1016/0360-3016(94)00449-u.
9
Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.调强放疗与三维适形放疗在食管癌根治性治疗中的比较:疗效与急性毒性对比
Radiat Oncol. 2017 Aug 15;12(1):131. doi: 10.1186/s13014-017-0863-3.
10
High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.食管癌同步放化疗后高剂量率近距离放疗增敏
Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):271-5. doi: 10.1016/s0360-3016(99)00184-4.

引用本文的文献

1
Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study.转移性或复发性食管鳞状细胞癌的免疫治疗联合或不联合放疗:一项真实世界研究
Clin Transl Radiat Oncol. 2022 Nov 2;38:130-137. doi: 10.1016/j.ctro.2022.10.011. eCollection 2023 Jan.
2
Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer.几种用于缓解食管癌症状的外照射放疗方案的有效性
Clin Transl Radiat Oncol. 2019 Apr 24;17:24-31. doi: 10.1016/j.ctro.2019.04.017. eCollection 2019 Jul.